東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/02/21 | 2,970 | 3,035 | 2,950 | 2,999 | -1 | ±0% | 188,400 |
2024/02/20 | 3,055 | 3,055 | 2,997 | 3,000 | -65 | -2.1% | 199,600 |
2024/02/19 | 2,980 | 3,075 | 2,980 | 3,065 | +102 | +3.4% | 169,400 |
2024/02/16 | 2,968 | 3,015 | 2,915 | 2,963 | +17 | +0.6% | 282,800 |
2024/02/15 | 3,230 | 3,240 | 2,917 | 2,946 | -249 | -7.8% | 501,000 |
2024/02/14 | 2,992 | 3,195 | 2,978 | 3,195 | +502 | +18.6% | 930,800 |
2024/02/13 | 2,665 | 2,696 | 2,643 | 2,693 | +56 | +2.1% | 188,600 |
2024/02/09 | 2,678 | 2,681 | 2,623 | 2,637 | -47 | -1.8% | 138,300 |
2024/02/08 | 2,664 | 2,707 | 2,647 | 2,684 | +17 | +0.6% | 151,600 |
2024/02/07 | 2,627 | 2,672 | 2,627 | 2,667 | +45 | +1.7% | 104,700 |
2024/02/06 | 2,666 | 2,666 | 2,601 | 2,622 | -39 | -1.5% | 126,400 |
2024/02/05 | 2,653 | 2,677 | 2,622 | 2,661 | +26 | +1% | 172,400 |
2024/02/02 | 2,599 | 2,642 | 2,582 | 2,635 | +15 | +0.6% | 145,500 |
2024/02/01 | 2,570 | 2,640 | 2,562 | 2,620 | +34 | +1.3% | 183,400 |
2024/01/31 | 2,551 | 2,586 | 2,546 | 2,586 | +20 | +0.8% | 125,700 |
2024/01/30 | 2,574 | 2,579 | 2,534 | 2,566 | -7 | -0.3% | 139,000 |
2024/01/29 | 2,511 | 2,579 | 2,509 | 2,573 | +81 | +3.3% | 119,200 |
2024/01/26 | 2,505 | 2,513 | 2,487 | 2,492 | -22 | -0.9% | 110,100 |
2024/01/25 | 2,552 | 2,563 | 2,505 | 2,514 | -43 | -1.7% | 115,400 |
2024/01/24 | 2,575 | 2,585 | 2,546 | 2,557 | -21 | -0.8% | 117,900 |
2024/01/23 | 2,578 | 2,615 | 2,565 | 2,578 | +4 | +0.2% | 139,500 |
2024/01/22 | 2,611 | 2,618 | 2,553 | 2,574 | -43 | -1.6% | 214,600 |
2024/01/19 | 2,637 | 2,650 | 2,571 | 2,617 | -14 | -0.5% | 251,300 |
2024/01/18 | 2,554 | 2,633 | 2,543 | 2,631 | +84 | +3.3% | 209,200 |
2024/01/17 | 2,550 | 2,601 | 2,537 | 2,547 | +43 | +1.7% | 205,500 |
2024/01/16 | 2,515 | 2,539 | 2,501 | 2,504 | -11 | -0.4% | 62,400 |
2024/01/15 | 2,470 | 2,544 | 2,470 | 2,515 | +31 | +1.2% | 119,300 |
2024/01/12 | 2,550 | 2,567 | 2,470 | 2,484 | -46 | -1.8% | 125,100 |
2024/01/11 | 2,523 | 2,535 | 2,501 | 2,530 | +13 | +0.5% | 105,400 |
2024/01/10 | 2,510 | 2,529 | 2,505 | 2,517 | +15 | +0.6% | 112,500 |
2024/01/09 | 2,434 | 2,509 | 2,431 | 2,502 | +92 | +3.8% | 180,200 |
2024/01/05 | 2,440 | 2,449 | 2,386 | 2,410 | -24 | -1% | 161,200 |
2024/01/04 | 2,366 | 2,434 | 2,326 | 2,434 | +82 | +3.5% | 130,800 |
2023/12/29 | 2,358 | 2,362 | 2,332 | 2,352 | -7 | -0.3% | 85,000 |
2023/12/28 | 2,360 | 2,362 | 2,343 | 2,359 | +2 | +0.1% | 74,200 |
2023/12/27 | 2,329 | 2,363 | 2,320 | 2,357 | +22 | +0.9% | 85,700 |
2023/12/26 | 2,368 | 2,369 | 2,330 | 2,335 | -22 | -0.9% | 83,100 |
2023/12/25 | 2,355 | 2,374 | 2,349 | 2,357 | +11 | +0.5% | 62,800 |
2023/12/22 | 2,326 | 2,350 | 2,312 | 2,346 | +26 | +1.1% | 100,600 |
2023/12/21 | 2,326 | 2,353 | 2,310 | 2,320 | -10 | -0.4% | 159,700 |
2023/12/20 | 2,315 | 2,350 | 2,315 | 2,330 | +30 | +1.3% | 96,400 |
2023/12/19 | 2,263 | 2,301 | 2,246 | 2,300 | +14 | +0.6% | 170,100 |
2023/12/18 | 2,227 | 2,295 | 2,223 | 2,286 | -3 | -0.1% | 138,400 |
2023/12/15 | 2,336 | 2,336 | 2,281 | 2,289 | -49 | -2.1% | 164,300 |
2023/12/14 | 2,335 | 2,351 | 2,308 | 2,338 | ±0 | ±0% | 110,300 |
2023/12/13 | 2,345 | 2,358 | 2,337 | 2,338 | -3 | -0.1% | 106,400 |
2023/12/12 | 2,370 | 2,379 | 2,340 | 2,341 | -32 | -1.3% | 103,100 |
2023/12/11 | 2,345 | 2,376 | 2,339 | 2,373 | +34 | +1.5% | 89,300 |
2023/12/08 | 2,370 | 2,381 | 2,329 | 2,339 | -52 | -2.2% | 110,300 |
2023/12/07 | 2,430 | 2,430 | 2,391 | 2,391 | -43 | -1.8% | 86,500 |
51~
100
件表示中 / 6703件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 271,100円 | +9.6% | +279.3% | 2.21% | 10.26倍 | 0.91倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
キッセイ薬 | 323,000円 | +9.8% | -12.1% | 2.79% | 12.64倍 | 0.65倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
住友ファーマ | 36,300円 | -43.4% | - | 0.00% | - | 0.35倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ネクセラファーマ | 154,600円 | +150.7% | - | 0.00% | 39.51倍 | 2.07倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ジーエヌアイ | 240,000円 | +52.1% | +23.3% | 0.00% | 16.96倍 | 3.54倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム